<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38856741</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2192-5682</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Global spine journal</Title><ISOAbbreviation>Global Spine J</ISOAbbreviation></Journal><ArticleTitle>Remineralization Rate of Lytic Lesions of the Spine in Multiple Myeloma Patients Undergoing Radiation Therapy.</ArticleTitle><Pagination><StartPage>1712</StartPage><EndPage>1724</EndPage><MedlinePgn>1712-1724</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/21925682241260651</ELocationID><Abstract><AbstractText>Study DesignRetrospective cohort study.ObjectiveIn general, Multiple Myeloma (MM) patients are treated with systemic therapy including chemotherapy. Radiation therapy can have an important supportive role in the palliative management of MM-related osteolytic lesions. Our study aims to investigate the degree of radiation-induced remineralization in MM patients to gain a better understanding of its potential impact on bone mineral density and, consequently, fracture prevention. Our primary outcome measure was percent change in bone mineral density measured in Hounsfield Units (&#x394;% HU) between pre- and post-radiation measurements, compared to non-targeted vertebrae.MethodsWe included 119 patients with MM who underwent radiotherapy of the spine between January 2010 and June 2021 and who had a CT scan of the spine at baseline and between 3-24 months after radiation. A linear mixed effect model tested any differences in remineralization rate per month (&#x3b2;<sub>difference</sub>) between targeted and non-targeted vertebrae.ResultsAnalyses of CT scans yielded 565 unique vertebrae (366 targeted and 199 non-targeted vertebrae). In both targeted and non-targeted vertebrae, there was an increase in bone density per month (&#x3b2;<sub>overall</sub> = .04; <i>P</i> = .002) with the largest effect being between 9-18 months post-radiation. Radiation did not cause a greater increase in bone density per month compared to non-targeted vertebrae (&#x3b2;<sub>difference</sub> = .67; <i>P</i> = .118).ConclusionOur results demonstrate that following radiation, bone density increased over time for both targeted and non-targeted vertebrae. However, no conclusive evidence was found that targeted vertebrae have a higher remineralization rate than non-targeted vertebrae in patients with MM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zijlstra</LastName><ForeName>Hester</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3962-6871</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation><Identifier Source="RINGGOLD">8124</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Te Velde</LastName><ForeName>Jens P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Striano</LastName><ForeName>Brendan M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groot</LastName><ForeName>Olivier Q</ForeName><Initials>OQ</Initials><Identifier Source="ORCID">0000-0002-5091-3110</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation><Identifier Source="RINGGOLD">8124</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Groot</LastName><ForeName>Tom M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raje</LastName><ForeName>Noopur</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Center for Multiple Myeloma, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Chirayu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husseini</LastName><ForeName>Jad</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delawi</LastName><ForeName>Diyar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands.</Affiliation><Identifier Source="RINGGOLD">72507</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kempen</LastName><ForeName>Diederik H R</ForeName><Initials>DHR</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, OLVG, Amsterdam, The Netherlands.</Affiliation><Identifier Source="RINGGOLD">10215</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verlaan</LastName><ForeName>Jorrit-Jan</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation><Identifier Source="RINGGOLD">8124</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwab</LastName><ForeName>Joseph H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation><Identifier Source="RINGGOLD">2348</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Global Spine J</MedlineTA><NlmUniqueID>101596156</NlmUniqueID><ISSNLinking>2192-5682</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hounsfield Units</Keyword><Keyword MajorTopicYN="N">bone remodeling</Keyword><Keyword MajorTopicYN="N">lytic lesions</Keyword><Keyword MajorTopicYN="N">multiple myeloma</Keyword><Keyword MajorTopicYN="N">radiotherapy</Keyword><Keyword MajorTopicYN="N">remineralization</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>10</Day><Hour>13</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>10</Day><Hour>13</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>10</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38856741</ArticleId><ArticleId IdType="pmc">PMC11571351</ArticleId><ArticleId IdType="doi">10.1177/21925682241260651</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitsiades CS, Mitsiades N, Munshi NC, Anderson KC. Focus on multiple myeloma. Cancer Cell. 2004;6(5):439-444. doi:10.1016/j.ccr.2004.10.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2004.10.020</ArticleId><ArticleId IdType="pubmed">15542427</ArticleId></ArticleIdList></Reference><Reference><Citation>Padala SA, Barsouk A, Barsouk A, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci. 2021;9(1):3. doi:10.3390/MEDSCI9010003</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/MEDSCI9010003</ArticleId><ArticleId IdType="pmc">PMC7838784</ArticleId><ArticleId IdType="pubmed">33498356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C, Bhatta S, Cyprien L, Fonseca R, Hernandez RK. Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data. J Bone Oncol. 2019;14:100215. doi:10.1016/j.jbo.2018.100215</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbo.2018.100215</ArticleId><ArticleId IdType="pmc">PMC6329702</ArticleId><ArticleId IdType="pubmed">30666288</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang RW, Campbell BA, Goda JS, et al. Radiation therapy for Solitary Plasmacytoma and multiple myeloma: Guidelines from the international Lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 2018;101(4):794-808. doi:10.1016/j.ijrobp.2018.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijrobp.2018.05.009</ArticleId><ArticleId IdType="pubmed">29976492</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonmez M, Akagun T, Topbas M, et al. Effect of pathologic fractures on survival in multiple myeloma patients: a case control study. J Exp Clin Cancer Res. 2008;27(1):11. doi:10.1186/1756-9966-27-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-9966-27-11</ArticleId><ArticleId IdType="pmc">PMC2438338</ArticleId><ArticleId IdType="pubmed">18577267</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvannasankha A, Grethlein SJ. Multiple myeloma treatment protocols. Medscape. Published May 11, 2021. Accessed October 13, 2021. https://emedicine.medscape.com/article/2006866</Citation></Reference><Reference><Citation>Rodr&#xed;guez-Lobato LG, Ganzetti M, Fern&#xe1;ndez de Larrea C, Hudecek M, Einsele H, Danhof S. CAR T-cells in multiple myeloma: State of the art and future directions. Front Oncol. 2020;10:1243. doi:10.3389/fonc.2020.01243</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.01243</ArticleId><ArticleId IdType="pmc">PMC7399644</ArticleId><ArticleId IdType="pubmed">32850376</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehlsen AD, Sindhu KK, Moshier E, et al. The safety and efficacy of radiation therapy with concurrent dexamethasone, cyclophosphamide, etoposide, and cisplatin-based systemic therapy for multiple myeloma. Clin Lymphoma Myeloma Leuk. 2022;22:192-197. doi:10.1016/j.clml.2021.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clml.2021.09.015</ArticleId><ArticleId IdType="pmc">PMC9040190</ArticleId><ArticleId IdType="pubmed">34736880</ArticleId></ArticleIdList></Reference><Reference><Citation>Momm F, Greil C, Sch&#xe4;fer H. Towards individualized radiation therapy in multiple myeloma. Haematologica. 2020;105(7):1763-1764. doi:10.3324/haematol.2019.243451</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2019.243451</ArticleId><ArticleId IdType="pmc">PMC7327648</ArticleId><ArticleId IdType="pubmed">32611577</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhammali A, Amini B, Ludmir EB, et al. New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity. Haematologica. 2020;105(7):e355-e357. doi:10.3324/haematol.2019.235804</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2019.235804</ArticleId><ArticleId IdType="pmc">PMC7327656</ArticleId><ArticleId IdType="pubmed">31919088</ArticleId></ArticleIdList></Reference><Reference><Citation>Pielkenrood BJ, Visser TF, van Tol FR, et al. Remineralization of lytic spinal metastases after radiotherapy. Spine J. 2023;23:571-578. doi:10.1016/j.spinee.2022.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2022.12.018</ArticleId><ArticleId IdType="pubmed">36623735</ArticleId></ArticleIdList></Reference><Reference><Citation>Koswig S, Budach V. [Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study]. Strahlenther Onkol. 1999;175(10):500-508. doi:10.1007/s000660050061</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000660050061</ArticleId><ArticleId IdType="pubmed">10554645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Sun B, Meng X, Liu C, Cong Y, Wu S. Density of bone metastatic lesions increases after radiotherapy in patients with breast cancer. J Radiat Res. 2019;60(3):394-400. doi:10.1093/jrr/rry098</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jrr/rry098</ArticleId><ArticleId IdType="pmc">PMC6530615</ArticleId><ArticleId IdType="pubmed">30785994</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster R, Eisele C, Bruckner T, et al. Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis. Radiat Oncol. 2015;10(1):62-69. doi:10.1186/s13014-015-0368-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13014-015-0368-x</ArticleId><ArticleId IdType="pmc">PMC4355128</ArticleId><ArticleId IdType="pubmed">25884703</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster R, Hees K, Bruckner T, et al. Survival and stability of patients with urothelial cancer and spinal bone metastases after palliative radiotherapy. Radiol Oncol. 2018;52(2):189-194. doi:10.1515/raon-2017-0038</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/raon-2017-0038</ArticleId><ArticleId IdType="pmc">PMC6043884</ArticleId><ArticleId IdType="pubmed">30018523</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuschek C, Ochtrop TA, B&#xf6;lke E, et al. Effects of radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a single institution. Radiat Oncol. 2015;10(1):71-79. doi:10.1186/s13014-015-0374-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13014-015-0374-z</ArticleId><ArticleId IdType="pmc">PMC4391087</ArticleId><ArticleId IdType="pubmed">25889851</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155-163. doi:10.1016/j.jcm.2016.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcm.2016.02.012</ArticleId><ArticleId IdType="pmc">PMC4913118</ArticleId><ArticleId IdType="pubmed">27330520</ArticleId></ArticleIdList></Reference><Reference><Citation>Introduction to Linear Mixed Models. UCLA: Statistical Consulting Group. Accessed
November 8, 2022. https://stats.oarc.ucla.edu/other/mult-pkg/introduction-to-linear-mixed-models/</Citation></Reference><Reference><Citation>Seabold S, Perktold J. Statsmodels: Econometric and statistical modeling with python. In: 9th Python in Science Conference; 2010.</Citation></Reference><Reference><Citation>Genant HK, Wu CY, Van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137-1148</Citation><ArticleIdList><ArticleId IdType="pubmed">8237484</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Zamagni E, Lentzsch S, et al. Treatment of multiple myeloma-related bone disease: recommendations from the bone working group of the international myeloma working group. Lancet Oncol. 2021;22(3):e119-e130. doi:10.1016/S1470-2045(20)30559-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30559-3</ArticleId><ArticleId IdType="pubmed">33545067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobeiha M, Moghadasian MH, Amin N, Jafarnejad S. RANKL/RANK/OPG pathway: a mechanism involved in Exercise-induced bone remodeling. BioMed Res Int. 2020;2020:6910312. doi:10.1155/2020/6910312</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6910312</ArticleId><ArticleId IdType="pmc">PMC7053481</ArticleId><ArticleId IdType="pubmed">32149122</ArticleId></ArticleIdList></Reference><Reference><Citation>Raje NS, Bhatta S, Terpos E. Role of the RANK/RANKL pathway in multiple myeloma. Clin Cancer Res. 2019;25(1):12-20. doi:10.1158/1078-0432.CCR-18-1537</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-18-1537</ArticleId><ArticleId IdType="pubmed">30093448</ArticleId></ArticleIdList></Reference><Reference><Citation>Fili S, Karalaki M, Schaller B. Therapeutic implications of osteoprotegerin. Cancer Cell Int. 2009;9:26. doi:10.1186/1475-2867-9-26</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2867-9-26</ArticleId><ArticleId IdType="pmc">PMC2754428</ArticleId><ArticleId IdType="pubmed">19747396</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanoudakis E, Papoutselis M, Terpos E, et al. Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma. Blood Cancer J. 2016;6(11):e500. doi:10.1038/bcj.2016.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bcj.2016.108</ArticleId><ArticleId IdType="pmc">PMC5148055</ArticleId><ArticleId IdType="pubmed">27834938</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo R, Lu W, Zhang Y, Cao X, Jin X, Zhao M. Targeting BCMA to Treat multiple myeloma: Updates from the 2021 ASH Annual Meeting. Front Immunol. 2022;13:839097. doi:10.3389/fimmu.2022.839097</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.839097</ArticleId><ArticleId IdType="pmc">PMC8936073</ArticleId><ArticleId IdType="pubmed">35320942</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SF, Anderson KC, Tai YT. Targeting B cell maturation antigen (BCMA) in multiple myeloma: potential uses of BCMA-based Immunotherapy. Front Immunol. 2018;9:1821. doi:10.3389/fimmu.2018.01821</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01821</ArticleId><ArticleId IdType="pmc">PMC6095983</ArticleId><ArticleId IdType="pubmed">30147690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleber M, Ntanasis-Stathopoulos I, Terpos E. BCMA in multiple myeloma&#x2014;a Promising Key to therapy. J Clin Med. 2021;10(18):4088. doi:10.3390/jcm10184088</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184088</ArticleId><ArticleId IdType="pmc">PMC8472544</ArticleId><ArticleId IdType="pubmed">34575199</ArticleId></ArticleIdList></Reference><Reference><Citation>Talamo G, Dimaio C, Abbi KKS, et al. Current role of radiation therapy for multiple myeloma. Front Oncol. 2015;5:40. doi:10.3389/fonc.2015.00040</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2015.00040</ArticleId><ArticleId IdType="pmc">PMC4332323</ArticleId><ArticleId IdType="pubmed">25741475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright LE, Buijs JT, Kim HS, et al. Single-limb Irradiation induces local and systemic bone loss in a murine model. J Bone Miner Res. 2015;30(7):1268-1279. doi:10.1002/jbmr.2458</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.2458</ArticleId><ArticleId IdType="pmc">PMC4478128</ArticleId><ArticleId IdType="pubmed">25588731</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico L, Roato I. Cross-talk between T cells and osteoclasts in bone resorption. BoneKEy Rep. 2012;1:82. doi:10.1038/bonekey.2012.82</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bonekey.2012.82</ArticleId><ArticleId IdType="pmc">PMC3727728</ArticleId><ArticleId IdType="pubmed">23951473</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa S, Reagan MR. Therapeutic irradiation: Consequences for bone and bone marrow adipose tissue. Front Endocrinol. 2019;10:587. doi:10.3389/fendo.2019.00587</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2019.00587</ArticleId><ArticleId IdType="pmc">PMC6727661</ArticleId><ArticleId IdType="pubmed">31555210</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaubauer AJ, Deloch L, Becker I, Fietkau R, Frey B, Gaipl US. The influence of radiation on bone and bone cells&#x2014;Differential effects on osteoclasts and osteoblasts. Int J Mol Sci. 2020;21(17):6377. doi:10.3390/ijms21176377</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176377</ArticleId><ArticleId IdType="pmc">PMC7504528</ArticleId><ArticleId IdType="pubmed">32887421</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Q, Hong W, Zhou Y, et al. Bone marrow stem cell dysfunction in radiation-induced abscopal bone loss. J Orthop Surg Res. 2016;11(1):3. doi:10.1186/s13018-015-0339-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-015-0339-9</ArticleId><ArticleId IdType="pmc">PMC4704383</ArticleId><ArticleId IdType="pubmed">26739584</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A, Lin T, Tribble MB, et al. PTH1-34 Alleviates radiotherapy-induced local bone loss by improving osteoblast and Osteocyte survival. Bone. 2014;67:33-40. doi:10.1016/j.bone.2014.06.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2014.06.030</ArticleId><ArticleId IdType="pmc">PMC4154509</ArticleId><ArticleId IdType="pubmed">24998454</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinbold WD, Wannenmacher M, Hodapp N, Adler CP. Osteodensitometry of vertebral metastases after radiotherapy using quantitative computed tomography. Skeletal Radiol. 1989;18(7):517-521. doi:10.1007/BF00351751</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00351751</ArticleId><ArticleId IdType="pubmed">2588030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P, Koller A, Sharma S. Physiology, bone remodeling. In: StatPearls. StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK499863/
Accessed 18 November 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">29763038</ArticleId></ArticleIdList></Reference><Reference><Citation>Croarkin E. Osteopenia in the patient with cancer. Phys Ther. 1999;79(2):196-201. doi:10.1093/ptj/79.2.196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/79.2.196</ArticleId><ArticleId IdType="pubmed">10029059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang K, K&#xf6;nig L, Bruckner T, et al. Stability of spinal bone lesions in patients with multiple myeloma after radiotherapy&#x2014;a retrospective analysis of 130 cases. Clin Lymphoma Myeloma Leuk. 2017;17(12):e99-e107. doi:10.1016/j.clml.2017.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clml.2017.09.005</ArticleId><ArticleId IdType="pubmed">28993162</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmiedel BJ, Scheible CA, Nuebling T, et al. RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia. Cancer Res. 2013;73(2):683-694. doi:10.1158/0008-5472.CAN-12-2280</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-12-2280</ArticleId><ArticleId IdType="pubmed">23139212</ArticleId></ArticleIdList></Reference><Reference><Citation>Oest ME, Policastro CG, Mann KA, Zimmerman ND, Damron TA. Longitudinal effects of single Hindlimb radiation therapy on bone strength and morphology at local and contralateral sites. J Bone Miner Res. 2018;33(1):99-112. doi:10.1002/jbmr.3289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3289</ArticleId><ArticleId IdType="pmc">PMC5776033</ArticleId><ArticleId IdType="pubmed">28902435</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai J, He F, Wang J, Chen J, Tong L, Zhu G. Influence of radiation exposure pattern on the bone injury and osteoclastogenesis in a rat model. Int J Mol Med. 2019;44(6):2265-2275. doi:10.3892/ijmm.2019.4369</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2019.4369</ArticleId><ArticleId IdType="pmc">PMC6844641</ArticleId><ArticleId IdType="pubmed">31638191</ArticleId></ArticleIdList></Reference><Reference><Citation>Raje N, Berdeja J, Lin Y, et al. Anti-BCMA CAR T-cell therapy bb2121 in Relapsed or refractory multiple myeloma. N Engl J Med. 2019;380(18):1726-1737. doi:10.1056/NEJMoa1817226</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1817226</ArticleId><ArticleId IdType="pmc">PMC8202968</ArticleId><ArticleId IdType="pubmed">31042825</ArticleId></ArticleIdList></Reference><Reference><Citation>Raje N, Terpos E, Willenbacher W, et al. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol. 2018;19(3):370-381. doi:10.1016/S1470-2045(18)30072-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(18)30072-X</ArticleId><ArticleId IdType="pubmed">29429912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YS, Heo W, Nam J, Jeung YH, Bae J. The combination of ionizing radiation and proteasomal inhibition by bortezomib enhances the expression of NKG2D ligands in multiple myeloma cells. J Radiat Res. 2018;59(3):245-252. doi:10.1093/jrr/rry005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jrr/rry005</ArticleId><ArticleId IdType="pmc">PMC5967576</ArticleId><ArticleId IdType="pubmed">29518205</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>